{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03975",
      "entity_text" : "FITC-LPS O111",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9JIF9",
      "entity_text" : "MYO",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We also observed that MYO and HF1 partly inhibited the binding of FITC-LPS O111 : B4 (XREF_FIG), but not the O55 : B5 serotype (XREF_FIG), to PMX, although HF1 displayed an enhancing effect at 1 mug/ml.",
  "reading_complete" : "2020-08-08T14:59:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:51:15Z",
  "trigger" : "inhibited",
  "evidence" : [ "MYO and HF1 partly inhibited the binding of FITC-LPS O111" ],
  "pmc_id" : "4889133",
  "score" : 0
}